A. Gregory Sorensen

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.

Thomas Benner, Percy Ivy, Marek Ancukiewicz, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An evidence‐based causative classification system for acute ischemic stroke

K. Furie, A. Sorensen, Wade S. Smith, 2005, Annals of neurology.

Early Experience of Translating pH-Weighted MRI to Image Human Subjects at 3 Tesla

Thomas Benner, A. Sorensen, T. Benner, 2010, Stroke.